|
|
Jian-Su Shao, Su-Li Cheng, Joyce M. Pingsterhaus, Nichole Charlton-Kachigian, Arleen P. Loewy, Dwight A. Towler
J Clin Invest. 2005;
115(5):1210
doi:10.1172/JCI24140
Abstract |
Full text
| PDF

I
n diabetic LDLR–/– mice, an ectopic BMP2-Msx2 gene regulatory program is upregulated in association with vascular calcification. We verified the procalcific actions of aortic Msx2 expression in vivo. CMV-Msx2 transgenic (CMV-Msx2Tg+) mice expressed 3-fold higher levels of aortic Msx2 than nontransgenic littermates. On high-fat diets, CMV-Msx2Tg+ mice exhibited marked cardiovascular calcification involving aortic and coronary tunica media. This corresponded to regions of Msx2 immunoreactivity in adjacent adventitial myofibroblasts, suggesting a potential paracrine osteogenic signal. To better understand Msx2-regulated calcification, we studied actions in 10T1/2 cells. We found that conditioned media from Msx2-transduced 10T1/2 cells (Msx2-CM) is both pro-osteogenic and adipostatic; these features are characteristic of Wnt signaling. Msx2-CM stimulated Wnt-dependent TCF/LEF transcription, and Msx2-transduced cells exhibited increased nuclear β-catenin localization with concomitant alkaline phosphatase induction. Msx2 upregulated Wnt3a and Wnt7a but downregulated expression of the canonical inhibitor Dkk1. Dkk1 treatment reversed osteogenic and adipostatic actions of Msx2. Teriparatide, a PTH1R agonist that inhibits murine vascular calcification, suppressed vascular BMP2-Msx2-Wnt signaling. Analyses of CMV-Msx2Tg+ mice confirmed that Msx2 suppresses aortic Dkk1 and upregulates vascular Wnts; moreover, TOPGAL+ (Wnt reporter); CMV-Msx2Tg+ mice exhibited augmented aortic LacZ expression. Thus, Msx2-expressing cells elaborated an osteogenic milieu that promotes vascular calcification in part via paracrine Wnt signals.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(20)
| Title and authors |
Publication |
Year |
Cardiovascular Calcification
Sophie E. P. New, Elena Aikawa
|
Circ J
|
2011 |
MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma
Y Zhai, A Iura, S Yeasmin, A B Wiese, R Wu, Y Feng, E R Fearon, K R Cho
|
Oncogene
|
2011 |
Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions.
J Akech, J J Wixted, K Bedard, M van der Deen, S Hussain, T A Guise, A J van Wijnen, J L Stein, L R Languino, D C Altieri, J Pratap, E Keller, G S Stein, J B Lian
|
Oncogene
|
2010 |
Journal Club
|
Kidney Int
|
2010 |
R-Spondin1 protects mice from chemotherapy or radiation-induced oral mucositis through the canonical Wnt/beta-catenin pathway.
Jingsong Zhao, Kyung-Ah Kim, Josephine De Vera, Servando Palencia, Marie Wagle, Arie Abo
|
Proc. Natl. Acad. Sci. U.S.A.
|
2009 |
Expression of gremlin, a bone morphogenetic protein antagonist,is associated with vascular calcification in uraemia
A. Jara, C. Chacon, M. E. Burgos, A. Droguett, A. Valdivieso, M. Ortiz, P. Troncoso, S. Mezzano
|
Nephrology Dialysis Transplantation
|
2008 |
Slowing the progression of aortic stenosis
Kameswari Maganti, Nalini Rajamannan
|
Curr Treat Options Cardio Med
|
2008 |
Bone morphogenetic proteins regulate osteoprotegerin and its ligands in human vascular smooth muscle cells
Kirsten Q. T. Nguyen, Ping Olesen, Thomas Ledet, Lars Melholt Rasmussen
|
Endocr
|
2007 |
Regulation of In Vitro Vascular Calcification by BMP4, VEGF and Wnt3a
Lyudmila Mikhaylova, Jennifer Malmquist, Maria Nurminskaya
|
Calcif Tissue Int
|
2007 |
CKD-MBD: impact on management of kidney disease
Hiroaki Ogata, Fumihiko Koiwa, Eriko Kinugasa, Tadao Akizawa
|
Clin Exp Nephrol
|
2007 |
|